Legofer (Iron Protein Succinylate)

Legofer, an oral iron supplement, is indicated for conditions related to iron deficiency and its hematologic consequences.

• Iron deficiency anemia: improves hemoglobin levels and replenishes depleted iron stores.
• Iron deficiency: restores normal iron concentrations and prevents progression to anemia.
• Pregnancy‑associated iron deficiency: supports maternal iron requirements to maintain healthy fetal development.

• Iron Protein Succinylate supplies elemental iron that is absorbed in the duodenum and proximal jejunum. The absorbed iron is incorporated into the heme moiety of hemoglobin and stored as ferritin in tissues, thereby correcting iron deficiency and supporting erythropoiesis. The compound’s succinylate moiety facilitates solubility and bioavailability, allowing efficient uptake and utilization by the body.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel movements.
• Diarrhea: loose stools.
• Dark-colored stools: harmless discoloration.
• Abdominal discomfort: cramping or pain.
• Metallic taste: transient after ingestion.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Anaphylaxis: rapid onset of severe hypersensitivity.
• Iron overload: signs of excess iron such as joint pain or organ dysfunction.
• Severe abdominal pain: persistent or worsening pain.
• Hypotension: sudden drop in blood pressure.
• Hematuria: blood in urine.

Before initiating therapy, evaluate iron status and underlying causes of deficiency.

• Assess iron parameters: confirm low ferritin or hemoglobin before use.
• Monitor hemoglobin: periodic checks to avoid excess iron.
• Avoid in hemochromatosis: contraindicated in iron overload disorders.
• Caution with gastrointestinal disease: patients with IBD may experience worsened symptoms.
• Take with food: reduces gastrointestinal irritation.
• Store at room temperature: keep in the original pack, protect from moisture.

Iron supplements can affect the absorption of several medications.

Major Interactions (Avoid)

• Tetracycline antibiotics: chelation reduces antibiotic efficacy.
• Fluoroquinolone antibiotics: decreased absorption when co‑administered.
• Levothyroxine: iron binds and lowers thyroid hormone absorption.
• Bisphosphonates: concurrent intake impairs both agents.
• Antacids containing aluminum or magnesium: form insoluble complexes.

Moderate Interactions (Monitor Closely)

• Proton pump inhibitors: may reduce iron absorption; monitor iron levels.
• Calcium supplements: compete for absorption pathways.
• Foods high in phytates (e.g., legumes, whole grains): can diminish iron uptake.
• Oral contraceptives: slight reduction in iron absorption; assess periodically.